BMG491BT1088 - Common Stock

We assign a fundamental rating of **4** out of 10 to **IVZ**. **IVZ** was compared to 220 industry peers in the **Capital Markets** industry. Both the profitability and financial health of **IVZ** have multiple concerns. **IVZ** has a correct valuation and a medium growth rate.

With a **Return On Assets** value of **-1.24%**, **IVZ** is not doing good in the industry: **80.65%** of the companies in the same industry are doing better.

The **Return On Equity** of **IVZ** (**-2.31%**) is worse than **78.80%** of its industry peers.

Looking at the **Return On Invested Capital**, with a value of **2.41%**, **IVZ** is doing worse than **66.36%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **IVZ** is significantly below the industry average of **17.69%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.24% | ||

ROE | -2.31% | ||

ROIC | 2.41% |

ROA(3y)1.8%

ROA(5y)1.66%

ROE(3y)3.73%

ROE(5y)3.79%

ROIC(3y)3.52%

ROIC(5y)3.73%

With a **Operating Margin** value of **14.12%**, **IVZ** is not doing good in the industry: **66.36%** of the companies in the same industry are doing better.

In the last couple of years the **Gross Margin** of **IVZ** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 14.12% | ||

PM (TTM) | N/A | ||

GM | 67.2% |

OM growth 3Y-11.2%

OM growth 5Y-9.93%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.12%

GM growth 5Y-0.48%

The number of shares outstanding for **IVZ** has been reduced compared to 1 year ago.

The number of shares outstanding for **IVZ** has been increased compared to 5 years ago.

Compared to 1 year ago, **IVZ** has a worse debt to assets ratio.

Based on the Altman-Z score of **0.99**, we must say that **IVZ** is in the distress zone and has some risk of bankruptcy.

The **Altman-Z score** of **IVZ** (**0.99**) is comparable to the rest of the industry.

A Debt/Equity ratio of **0.52** indicates that **IVZ** is somewhat dependend on debt financing.

Looking at the **Debt to Equity ratio**, with a value of **0.52**, **IVZ** is in the better half of the industry, outperforming **68.20%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.52 | ||

Debt/FCF | 5.5 | ||

Altman-Z | 0.99 |

ROIC/WACCN/A

WACCN/A

A Current Ratio of **0.80** indicates that **IVZ** may have some problems paying its short term obligations.

The **Current ratio** of **IVZ** (**0.80**) is worse than **64.06%** of its industry peers.

A Quick Ratio of **0.80** indicates that **IVZ** may have some problems paying its short term obligations.

The **Quick ratio** of **IVZ** (**0.80**) is worse than **63.59%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.8 | ||

Quick Ratio | 0.8 |

The **Earnings Per Share** has grown by an nice **11.27%** over the past year.

Measured over the past years, **IVZ** shows a decrease in **Earnings Per Share**. The EPS has been decreasing by **-9.08%** on average per year.

Measured over the past years, **IVZ** shows a small growth in **Revenue**. The Revenue has been growing by **1.47%** on average per year.

EPS 1Y (TTM)11.27%

EPS 3Y-8.01%

EPS 5Y-9.08%

EPS Q2Q%38.71%

Revenue 1Y (TTM)1.11%

Revenue growth 3Y-2.38%

Revenue growth 5Y1.47%

Sales Q2Q%-0.45%

The **Earnings Per Share** is expected to grow by **5.78%** on average over the next years.

The **Revenue** is expected to grow by **2.71%** on average over the next years.

EPS Next Y8.53%

EPS Next 2Y9.9%

EPS Next 3Y10.98%

EPS Next 5Y5.78%

Revenue Next Year-0.16%

Revenue Next 2Y2.04%

Revenue Next 3Y2.71%

Revenue Next 5YN/A

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Based on the **Price/Earnings** ratio of **9.96**, the valuation of **IVZ** can be described as reasonable.

Based on the **Price/Earnings** ratio, **IVZ** is valued a bit cheaper than 69.12% of the companies in the same industry.

Compared to an average S&P500 **Price/Earnings** ratio of **29.65**, **IVZ** is valued rather cheaply.

A **Price/Forward Earnings** ratio of **8.63** indicates a reasonable valuation of **IVZ**.

Based on the **Price/Forward Earnings** ratio, **IVZ** is valued a bit cheaper than 72.35% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.96 | ||

Fwd PE | 8.63 |

Based on the **Enterprise Value to EBITDA** ratio, **IVZ** is valued a bit cheaper than the industry average as 77.88% of the companies are valued more expensively.

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **IVZ** indicates a rather cheap valuation: **IVZ** is cheaper than 82.49% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 5.15 | ||

EV/EBITDA | 13.75 |

The **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

PEG (NY)1.17

PEG (5Y)N/A

EPS Next 2Y9.9%

EPS Next 3Y10.98%

With a **Yearly Dividend Yield** of **5.01%**, **IVZ** is a good candidate for dividend investing.

Compared to an average S&P500 **Dividend Yield** of **2.26**, **IVZ** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.01% |

The dividend of **IVZ** has a limited annual growth rate of **1.50%**.

The dividend of **IVZ** decreased in the last 3 years.

Dividend Growth(5Y)1.5%

Div Incr Years2

Div Non Decr Years2

The dividend of **IVZ** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP-178.08%

EPS Next 2Y9.9%

EPS Next 3Y10.98%

**INVESCO LTD**

NYSE:IVZ (9/6/2024, 8:22:19 PM)

After market: 15.74 0 (0%)**15.74**

**-0.63 (-3.85%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap7.08B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.01% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.96 | ||

Fwd PE | 8.63 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.17

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -1.24% | ||

ROE | -2.31% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 14.12% | ||

PM (TTM) | N/A | ||

GM | 67.2% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.21

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.52 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.8 | ||

Quick Ratio | 0.8 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)11.27%

EPS 3Y-8.01%

EPS 5Y

EPS Q2Q%

EPS Next Y8.53%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)1.11%

Revenue growth 3Y-2.38%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y